 "SII will sell vaccine for Rs 200 to govt, Rs 1,000 to public: Report")
The Oxford vaccine will be sold for Rs 200 per dose to the government while it will be available for Rs 1,000 for the general public, Adar Poonawalla, chief executive of Serum Institute of India, was quoted as saying by a TV channel on Sunday.
His comments come after the country's drug regulator cleared its Covishield vaccine for emergency approval in India. Poonawalla said that Covishield vaccine, developed by Serum Institute of India in partnership with the Oxford University and pharma major AstraZeneca, is "safe and effective" against coronavirus.
According to Poonawalla, his firm is making between 50 and 60 million doses a month of the AstraZeneca/Oxford vaccine, which is cheaper than the Pfizer-BioNTech jab and easier to store and transport. He said that his company is waiting to get into an agreement with the government and added that the vaccine will be rolled out in the next 7-10 days.
Poonawalla said that Serum Institute has the capacity to manufacture 5,000 doses of vaccine per minute and already 40 to 50 million doses of the vaccine is ready for dispatch. Speaking on exporting Oxford vaccine to other countries, Poonawalla said that his company is in bilateral agreement with Bangladesh, Saudi Arabia and 66 other countries and will also look towards exporting the vaccine to them soon after India's vaccination drive is in advanced stage.
His comments come after the country's drug regulator cleared its Covishield vaccine for emergency approval in India. Poonawalla said that Covishield vaccine, developed by Serum Institute of India in partnership with the Oxford University and pharma major AstraZeneca, is "safe and effective" against coronavirus.
According to Poonawalla, his firm is making between 50 and 60 million doses a month of the AstraZeneca/Oxford vaccine, which is cheaper than the Pfizer-BioNTech jab and easier to store and transport. He said that his company is waiting to get into an agreement with the government and added that the vaccine will be rolled out in the next 7-10 days.
Poonawalla said that Serum Institute has the capacity to manufacture 5,000 doses of vaccine per minute and already 40 to 50 million doses of the vaccine is ready for dispatch. Speaking on exporting Oxford vaccine to other countries, Poonawalla said that his company is in bilateral agreement with Bangladesh, Saudi Arabia and 66 other countries and will also look towards exporting the vaccine to them soon after India's vaccination drive is in advanced stage.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%